Miscarriage patients have fewer treatment options in states with abortion bans, study shows

A study found that pregnant patients experiencing miscarriage in states with abortion bans have fewer healthcare options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective misoprostol-only treatments. The study also noted increased use of expectant management, which carries higher risks of complications.